Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Poliovirus Receptor (CD155) Expression in Pediatric Brain Tumors Mediates Oncolysis of Medulloblastoma and Pleomorphic Xanthoastrocytoma.

Thompson EM, Brown M, Dobrikova E, Ramaswamy V, Taylor MD, McLendon R, Sanks J, Chandramohan V, Bigner D, Gromeier M.

J Neuropathol Exp Neurol. 2018 Aug 1;77(8):696-702. doi: 10.1093/jnen/nly045.

PMID:
29878245
2.

Validation of an Immunohistochemistry Assay for Detection of CD155, the Poliovirus Receptor, in Malignant Gliomas.

Chandramohan V, Bryant JD, Piao H, Keir ST, Lipp ES, Lefaivre M, Perkinson K, Bigner DD, Gromeier M, McLendon RE.

Arch Pathol Lab Med. 2017 Dec;141(12):1697-1704. doi: 10.5858/arpa.2016-0580-OA. Epub 2017 Aug 22.

3.

Engineered Oncolytic Poliovirus PVSRIPO Subverts MDA5-Dependent Innate Immune Responses in Cancer Cells.

Walton RW, Brown MC, Sacco MT, Gromeier M.

J Virol. 2018 Sep 12;92(19). pii: e00879-18. doi: 10.1128/JVI.00879-18. Print 2018 Oct 1.

4.

Poliovirus receptor CD155-targeted oncolysis of glioma.

Merrill MK, Bernhardt G, Sampson JH, Wikstrand CJ, Bigner DD, Gromeier M.

Neuro Oncol. 2004 Jul;6(3):208-17.

5.

Recurrent Glioblastoma Treated with Recombinant Poliovirus.

Desjardins A, Gromeier M, Herndon JE 2nd, Beaubier N, Bolognesi DP, Friedman AH, Friedman HS, McSherry F, Muscat AM, Nair S, Peters KB, Randazzo D, Sampson JH, Vlahovic G, Harrison WT, McLendon RE, Ashley D, Bigner DD.

N Engl J Med. 2018 Jul 12;379(2):150-161. doi: 10.1056/NEJMoa1716435. Epub 2018 Jun 26.

6.

Atypical teratoid/rhabdoid tumor arising in pleomorphic xanthoastrocytoma: a case report.

Jeong JY, Suh YL, Hong SW.

Neuropathology. 2014 Aug;34(4):398-405.

PMID:
25268025
7.

Oncolytic Herpes Virus rRp450 Shows Efficacy in Orthotopic Xenograft Group 3/4 Medulloblastomas and Atypical Teratoid/Rhabdoid Tumors.

Studebaker AW, Hutzen BJ, Pierson CR, Haworth KB, Cripe TP, Jackson EM, Leonard JR.

Mol Ther Oncolytics. 2017 May 25;6:22-30. doi: 10.1016/j.omto.2017.05.005. eCollection 2017 Sep 15.

8.

Pleomorphic Xanthoastrocytoma: Natural History and Long-Term Follow-Up.

Ida CM, Rodriguez FJ, Burger PC, Caron AA, Jenkins SM, Spears GM, Aranguren DL, Lachance DH, Giannini C.

Brain Pathol. 2015 Sep;25(5):575-86. doi: 10.1111/bpa.12217. Epub 2014 Dec 5.

9.

Role of a Promoter Mutation in the Telomerase Reverse Transcriptase Gene in Malignant Transformation of Pleomorphic Xanthoastrocytoma.

Hosono J, Nitta M, Masui K, Maruyama T, Komori T, Yokoo H, Saito T, Muragaki Y, Kawamata T.

World Neurosurg. 2018 Dec 29. pii: S1878-8750(18)32918-8. doi: 10.1016/j.wneu.2018.12.095. [Epub ahead of print]

PMID:
30599247
10.

BRAF mutation and anaplasia may be predictive factors of progression-free survival in adult pleomorphic xanthoastrocytoma.

Tabouret E, Bequet C, Denicola├» E, Barri├ę M, Nanni I, Metellus P, Dufour H, Chinot O, Figarella-Branger D.

Eur J Surg Oncol. 2015 Dec;41(12):1685-90. doi: 10.1016/j.ejso.2015.09.012. Epub 2015 Sep 30.

PMID:
26454767
11.

BRAF V600E mutations are common in pleomorphic xanthoastrocytoma: diagnostic and therapeutic implications.

Dias-Santagata D, Lam Q, Vernovsky K, Vena N, Lennerz JK, Borger DR, Batchelor TT, Ligon KL, Iafrate AJ, Ligon AH, Louis DN, Santagata S.

PLoS One. 2011 Mar 29;6(3):e17948. doi: 10.1371/journal.pone.0017948.

12.

A case of anaplastic pleomorphic xanthoastrocytoma presenting with tumor bleeding and cerebrospinal fluid dissemination.

Asano K, Miyamoto S, Kubo O, Kikkukawa T, Yagihashi A, Ohkuma H.

Brain Tumor Pathol. 2006 Apr;23(1):55-63.

PMID:
18095120
13.

Robust infectivity and replication of Delta-24 adenovirus induce cell death in human medulloblastoma.

Stolarek R, Gomez-Manzano C, Jiang H, Suttle G, Lemoine MG, Fueyo J.

Cancer Gene Ther. 2004 Nov;11(11):713-20.

PMID:
15332115
14.

Antitumor effect in medulloblastoma cells by gefitinib: Ectopic HER2 overexpression enhances gefitinib effects in vivo.

Meco D, Servidei T, Riccardi A, Ferlini C, Cusano G, Zannoni GF, Giangaspero F, Riccardi R.

Neuro Oncol. 2009 Jun;11(3):250-9. doi: 10.1215/15228517-2008-095. Epub 2008 Nov 25.

15.

Atypical teratoid rhabdoid tumor arising in a pleomorphic xanthoastrocytoma: a rare entity.

Uner M, Saglam A, Meydan BC, Aslan K, Soylemezoglu F.

Clin Neuropathol. 2017 Sep/Oct;36(5):227-232. doi: 10.5414/NP301017.

PMID:
28502320
16.

Combined pleomorphic xanthoastrocytoma-ganglioglioma with BRAF V600E mutation: case report.

Cicuendez M, Martinez-Saez E, Martinez-Ricarte F, Asanza EC, Sahuquillo J.

J Neurosurg Pediatr. 2016 Jul;18(1):53-7. doi: 10.3171/2016.1.PEDS15558. Epub 2016 Mar 25.

PMID:
27015517
17.

Clinicopathological characteristics of atypical teratoid/rhabdoid tumor.

Oka H, Scheithauer BW.

Neurol Med Chir (Tokyo). 1999 Jul;39(7):510-7; discussion 517-8.

18.

Xenotransplantation of pediatric low grade gliomas confirms the enrichment of BRAF V600E mutation and preservation of CDKN2A deletion in a novel orthotopic xenograft mouse model of progressive pleomorphic xanthoastrocytoma.

Kogiso M, Qi L, Lindsay H, Huang Y, Zhao X, Liu Z, Braun FK, Du Y, Zhang H, Bae G, Zhao S, Injac SG, Sobieski M, Brunell D, Mehta V, Tran D, Murray J, Baxter PA, Yuan XJ, Su JM, Adesina A, Perlaky L, Chintagumpala M, Parsons DW, Lau CC, Stephan CC, Lu X, Li XN.

Oncotarget. 2017 Sep 8;8(50):87455-87471. doi: 10.18632/oncotarget.20713. eCollection 2017 Oct 20.

19.

Combined "Infiltrating Astrocytoma/Pleomorphic Xanthoastrocytoma" Harboring IDH1 R132H and BRAF V600E Mutations.

Yamada S, Kipp BR, Voss JS, Giannini C, Raghunathan A.

Am J Surg Pathol. 2016 Feb;40(2):279-84. doi: 10.1097/PAS.0000000000000515.

PMID:
26414224
20.

Primary multicentric anaplastic pleomorphic xanthoastrocytoma with atypical features.

Montano N, Papacci F, Cioni B, Gaudino S, Della Pepa GM, Conforti G, Di Bonaventura R, Novello M, Lauriola L, Meglio M.

J Clin Neurosci. 2013 Nov;20(11):1605-8. doi: 10.1016/j.jocn.2012.09.046. Epub 2013 Jul 1.

PMID:
23827171

Supplemental Content

Support Center